FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|March 30, 2021
COVID-19 Updates: US and Global Cases, Deaths, and Vaccinations as of March 30, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 28.9% of total US population have received at least 1 dose
• 16.1% of total US population are fully vaccinated
• 16.1% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. New Mexico: 23.2%
2. Alaska: 22.1%
3. South Dakota: 22%
4. Rhode Island: 20.7%
5. North Dakota: 20.2%
2. Alaska: 22.1%
3. South Dakota: 22%
4. Rhode Island: 20.7%
5. North Dakota: 20.2%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 30 349 019 confirmed cases
• 550 165 deaths
• 550 165 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 664 407
2. Texas: 2 786 470
3. Florida: 2 047 379
4. New York: 1 861 491
5. Illinois: 1 239 502
2. Texas: 2 786 470
3. Florida: 2 047 379
4. New York: 1 861 491
5. Illinois: 1 239 502
Deaths: California has the most deaths due to COVID-19 with 59 030 reported fatalities, followed by New York with 50 158, and Texas with 48 135.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 127 880 539 confirmed cases, 2 795 587 deaths, and 72 555 518 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
The FDA granted Breakthrough Device designation to Natera's cell-free DNA multi-cancer early detection assay. What it means for primary care.
Most adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood screening test.
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
2
Most Adolescents With Colorectal Cancer Diagnosed at Advanced Stage, Study Finds
3
Building Clinician Confidence to Prescribe HIV PrEP in Primary Care
4
PrEP Deserts: Why HIV Prevention Still Misses Those at Risk
5